Veraxa Biotech is trading 5.56% down now at $1.36 after extending declines from its August 27, 2026 close of $1.44; no credible company-specific announcement or filing dated August 28, 2026 was identified.
- The latest investor-relations release was published August 24.
- It described a positive research milestone.
- The current decline remains unexplained rather than tied to fresh news.